Shufro Rose & Co’s Humana HUM Stock Holding History

Shufro Rose & Co’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-794	Closed	-$210K	–	321
2025 Q3	$210K	Hold	794	–	–	0.02%	282
2025 Q2	$210K	Hold	794	–	–	0.02%	278
2025 Q1	$210K	Buy	+794	New	+$215K	0.02%	281

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Shufro Rose & Co's HUM Position: Q4 2025 in Review

Shufro Rose & Co sold out of Humana (HUM) in Q4 2025, closing a stake of 794 shares — an estimated $210K sold.

Shufro Rose & Co first reported a position in HUM in Q1 2025 and held it in 3 quarters. The position peaked at $210K in Q3 2025. 863 funds tracked by Wall St. Rank hold HUM as of Q4 2025.

Shufro Rose & Co reported no remaining Humana position as of Q4 2025 after selling out during the quarter.
Shufro Rose & Co sold 794 Humana shares in Q4 2025, an estimated $210K.
Shufro Rose & Co first reported a position in Humana in Q1 2025 and held it in 3 quarters.
Shufro Rose & Co's Humana position peaked at $210K in Q3 2025.
863 funds tracked by Wall St. Rank held Humana as of Q4 2025.

Based on Shufro Rose & Co's 13F filing for Q4 2025, filed 9 Feb 2026.